Concepts and consequences of Eph receptor clustering

Seminars in Cell and Developmental Biology

Volumn 23, Issue 1, 2012, Pages 43-50

  Janes, Peter W ^a   Nievergall, Eva ^a,b   Lackmann, Martin ^a  

^a MONASH UNIVERSITY   (Australia)

^b Haematology Department   (Australia)

Author keywords

Eph oligomerisation; Eph receptors; Ephrins; Heterotypic EphA EphB clusters; Homotypic Eph Eph clusters

Indexed keywords

ADAM10 ENDOPEPTIDASE; EPHRIN; EPHRIN RECEPTOR; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A3; EPHRIN RECEPTOR A4; EPHRIN RECEPTOR A7; EPHRIN RECEPTOR B1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; EPHRIN RECEPTOR B4; EPHRIN RECEPTOR B6; LIGAND; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CANCER INVASION; CELL ADHESION; CELL CONTACT; CELL INTERACTION; CELL JUNCTION; CELL STRUCTURE; EMBRYO DEVELOPMENT; ENZYME REGULATION; EXTRACELLULAR SPACE; INTERNALIZATION; METASTASIS; NONHUMAN; OLIGOMERIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW;

EID: 84857441823     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.01.001     Document Type: Review

References (128)

1. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001, 411(6835):355-365.
2. Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol 2009, 21(2):140-146.
3. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141(7):1117-1134.
4. Kullander K., Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002, 3(7):475-486.
5. Davy A., Soriano P. Ephrin signaling in vivo: look both ways. Dev Dyn 2005, 232(1):1-10.
6. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008, 133(1):38-52.
7. Poliakov A., Cotrina M., Wilkinson D.G. Diverse roles of Eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 2004, 7(4):465-480.
8. Lackmann M., Boyd A.W. Eph, a protein family coming of age: more confusion, insight, or complexity?. Sci Signal 2008, 1(15):re2.
9. Janes P.W., Adikari S., Lackmann M. Eph/ephrin signalling and function in oncogenesis: lessons from embryonic development. Curr Cancer Drug Targets 2008, 8(6):473-479.
10. Pasquale E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010, 10(3):165-180.
11. Holmberg J., Frisen J. Ephrins are not only unattractive. Trends Neurosci 2002, 25(5):239-243.
12. Halloran M.C., Wolman M.A. Repulsion or adhesion: receptors make the call. Curr Opin Cell Biol 2006, 18(5):533-540.
13. Sela-Donenfeld D., Wilkinson D.G. Eph receptors: two ways to sharpen boundaries. Curr Biol 2005, 15(6):R210-R212.
14. Pawson T. Dynamic control of signaling by modular adaptor proteins. Curr Opin Cell Biol 2007, 19(2):112-116.
15. Vearing C.J., Lackmann M. Eph receptor signalling; dimerisation just isn't enough. Growth Factors 2005, 23(1):67-76.
16. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 1997, 90:403-404. Eph Nomenclature Committee.
17. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996, 17(1):9-19.
18. Kullander K., Butt S.J., Lebret J.M., Lundfald L., Restrepo C.E., Rydström A., et al. Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science 2003, 299(5614):1889-1892.
19. Kullander K., Croll S.D., Zimmer M., Pan L., McClain J., Hughes V., et al. Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing: allowing for unilateral motor control. Genes Dev 2001, 15(7):877-888.
20. Himanen J.P., Chumley M.J., Lackmann M., Li C., Barton W.A., Jeffrey P.D., et al. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 2004, 7(5):501-509.
21. Himanen J.P. Ectodomain structures of Eph receptors. Semin Cell Dev Biol 2011, (1096-3634) [Epub ahead of print Oct 24, 2011].
22. Himanen J.P., Yermekbayeva L., Janes P.W., Walker J.R., Xu K., Atapattu L., et al. Architecture of Eph receptor clusters. Proc Natl Acad Sci USA 2010, 107(24):10860-10865.
23. Seiradake E., Harlos K., Sutton G., Aricescu A.R., Jones E.Y. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat Struct Mol Biol 2010, 17(4):398-402.
24. Davis S., Gale N.W., Aldrich T.H., Maisonpierre P.C., Lhotak V., Pawson T., et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 1994, 266(5186):816-819.
25. Carter N., Nakamoto T., Hirai H., Hunter T. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat Cell Biol 2002, 4(8):565-573.
26. Dobrzanski P., Hunter K., Jones-Bolin S., Chang H., Robinson C., Pritchard S., et al. Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res 2004, 64(3):910-919.
27. Lackmann M., Oates A.C., Dottori M., Smith F.M., Do C., Power M., et al. Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J Biol Chem 1998, 273(32):20228-20237.
28. Lawrenson I.D., Wimmer-Kleikamp S.H., Lock P., Schoenwaelder S.M., Down M., Boyd A.W., et al. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J Cell Sci 2002, 115(Pt 5):1059-1072.
29. Marquardt T., Shirasaki R., Ghosh S., Andrews S.E., Carter N., Hunter T., et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005, 121(1):127-139.
30. Gauthier L.R., Robbins S.M. Ephrin signaling: one raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them?. Life Sci 2003, 74(2-3):207-216.
31. Stein E., Lane A.A., Cerretti D.P., Schoecklmann H.O., Schroff A.D., Van Etten R.L., et al. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes: attachment, and assembly responses. Genes Dev 1998, 12(5):667-678.
32. Himanen J.P., Rajashankar K.R., Lackmann M., Cowan C.A., Henkemeyer M., Nikolov D.B., et al. Crystal structure of an Eph receptor-ephrin complex. Nature 2001, 414(6866):933-938.
33. Boyd A.W., Lackmann M. Signals from Eph and ephrin proteins: a developmental tool kit. Sci STKE 2001, 2001(112):RE20.
34. Reber M., Burrola P., Lemke G. A relative signalling model for the formation of a topographic neural map. Nature 2004, 431(7010):847-853.
35. Lemke G., Reber M. Retinotectal mapping: new insights from molecular genetics. Annu Rev Cell Dev Biol 2005, 21:551-580.
36. Himanen J.-P., Saha N., Nikolov D.B. Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol 2007, 19(5):534.
37. Noren N.K., Yang N.Y., Silldorff M., Mutyala R., Pasquale E.B. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem J 2009, 422(3):433-442.
38. Tanaka M., Kamo T., Ota S., Sugimura H. Association of Dishevelled with Eph tyrosine kinase receptor and ephrin mediates cell repulsion. EMBO J 2003, 22(4):847-858.
39. van der Geer P., Hunter T., Lindberg R.A. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994, 10:251-337.
40. Lackmann M., Mann R.J., Kravets L., Smith F.M., Bucci T.A., Maxwell K.F., et al. Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J Biol Chem 1997, 272(26):16521-16530.
41. Wimmer-Kleikamp S.H., Janes P.W., Squire A., Bastiaens P.I., Lackmann M. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J Cell Biol 2004, 164(5):661-666.
42. Day B., To C., Himanen J.P., Smith F.M., Nikolov D.B., Boyd A.W., et al. Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J Biol Chem 2005, 280(28):26526-26532.
43. Smith F.M., Vearing C., Lackmann M., Treutlein H., Himanen J., Chen K., et al. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem 2004, 279(10):9522-9531.
44. Goldgur Y., Paavilainen S., Nikolov D., Himanen J.P. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009, 65(Pt 2):71-74.
45. Singla N., Goldgur Y., Xu K., Paavilainen S., Nikolov D.B., Himanen J.P. Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations. Biochem Biophys Res Commun 2010, 399(4):555-559.
46. Oates A.C., Lackmann M., Power M.A., Brennan C., Down L.M., Do C., et al. An early developmental role for Eph-ephrin interaction during vertebrate gastrulation. Mech Dev 1999, 83(1-2):77-94.
47. Carvalho R.F., Beutler M., Marler K.J., Knöll B., Becker-Barroso E., Heintzmann R., et al. Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci 2006, 9(3):322-330.
48. Kao T.J., Kania A. Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron 2011, 71(1):76-91.
49. Finger C., Escher C., Schneider D. The single transmembrane domains of human receptor tyrosine kinases encode self-interactions. Sci Signal 2009, 2(89):ra56.
50. Fleishman S.J., Schlessinger J., Ben-Tal N. A putative molecular-activation switch in the transmembrane domain of erbB2. Proc Natl Acad Sci USA 2002, 99(25):15937-15940.
51. Moriki T., Maruyama H., Maruyama I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 2001, 311(5):1011-1026.
52. Bocharov E.V., Mayzel M.L., Volynsky P.E., Goncharuk M.V., Ermolyuk Y.S., Schulga A.A., et al. Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J Biol Chem 2008, 283(43):29385-29395.
53. Bocharov E.V., Mayzel M.L., Volynsky P.E., Mineev K.S., Tkach E.N., Ermolyuk Y.S., et al. Left-handed dimer of EphA2 transmembrane domain: helix packing diversity among receptor tyrosine kinases. Biophys J 2010, 98(5):881-889.
54. Qiao F., Bowie J.U. The many faces of SAM. Sci STKE 2005, 2005(286):re7.
55. Smalla M., Schmieder P., Kelly M., Ter Laak A., Krause G., Ball L., et al. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites. Protein Sci 1999, 8(10):1954-1961.
56. Thanos C.D., Faham S., Goodwill K.E., Cascio D., Phillips M., Bowie J.U. Monomeric structure of the human EphB2 sterile alpha motif domain. J Biol Chem 1999, 274(52):37301-37306.
57. Stapleton D., Balan I., Pawson T., Sicheri F. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol 1999, 6(1):44-49.
58. Zhuang G., Hunter S., Hwang Y., Chen J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidyl inositol 3-kinase-dependent Rac1 activation. J Biol Chem 2007, 282(4):2683-2694.
59. Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y. EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. J Cell Sci 2009, 122(2):243-255.
60. Stein E., Cerretti D.P., Daniel T.O. Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells. J Biol Chem 1996, 271(38):23588-23593.
61. Fang W.B., Brantley-Sieders D.M., Hwang Y., Ham A.J., Chen J. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J Biol Chem 2008, 283(23):16017-16026.
62. Noren N.K., Pasquale E.B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 2004, 16(6):655-666.
63. Becker E., Huynh-Do U., Holland S., Pawson T., Daniel T.O., Skolnik E.Y. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. Mol Cell Biol 2000, 20(5):1537-1545.
64. Noren N.K., Foos G., Hauser C.A., Pasquale E.B. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 2006, 8(8):815-825.
65. Hu T., Shi G., Larose L., Rivera G.M., Mayer B.J., Zhou R. Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1. Biochemistry 2009, 48(27):6369-6378.
66. Nievergall E., Lackmann M., Janes P.W. Eph-dependent cell-cell adhesion and segregation in development and cancer. Cell Mol Life Sci 2011, [Epub ahead of print Dec 2011].
67. Salaita K., Nair P.M., Petit R.S., Neve R.M., Das D., Gray J.W., et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 2010, 327(5971):1380-1385.
68. Freywald A., Sharfe N., Roifman C.M. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1 2002, 277(6):3823-3828.
69. Truitt L., Freywald T., DeCoteau J., Sharfe N., Freywald A. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. Cancer Res 2010, 70(3):1141-1153.
70. Bush J.O., Soriano P. Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries. Genes Dev 2010, 24(18):2068-2080.
71. Jorgensen C., Sherman A., Chen G.I., Pasculescu A., Poliakov A., Hsiung M., et al. Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 2009, 326(5959):1502-1509.
72. Oricchio E., Nanjangud G., Wolfe A.L., Schatz J.H., Mavrakis K.J., Jiang M., et al. The eph-receptor a7 is a soluble tumor suppressor for follicular lymphoma. Cell 2011, 147(3):554-564.
73. Janes P.W., Griesshaber B., Atapattu L., Nievergall E., Hii L.L., Mensinga A., et al. Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. J Cell Biol 2011, 195(6):1033-1045.
74. Vearing C., Lee F.T., Wimmer-Kleikamp S., Spirkoska V., To C., Stylianou C., et al. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res 2005, 65(15):6745-6754.
75. Astin J.W., Batson J., Kadir S., Charlet J., Persad R.A., Gillatt D., et al. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol 2010, 12(12):1194-1204.
76. Davies H., Hunter C., Smith R., Stephens P., Greenman C., Bignell G., et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 2005, 65(17):7591-7595.
77. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314(5797):268-274.
78. Wood L.D., Calhoun E.S., Silliman N., Ptak J., Szabo S., Powell S.M., et al. Somatic mutations of GUCY2F: EPHA3, and NTRK3 in human cancers. Hum Mutat 2006, 27(10):1060-1061.
79. Ding L., Getz G., Wheeler D.A., Mardis E.R., McLellan M.D., Cibulskis K., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455(7216):1069-1075.
80. Hattori M., Osterfield M., Flanagan J.G. Regulated cleavage of a contact-mediated axon repellent. Science 2000, 289(5483):1360-1365.
81. Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H., Nievergall E., et al. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005, 123(2):291-304.
82. Wybenga-Groot L.E., Baskin B., Ong S.H., Tong J., Pawson T., Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 2001, 106(6):745-757.
83. Janes P.W., Wimmer-Kleikamp S.H., Frangakis A.S., Treble K., Griesshaber B., Sabet O., et al. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol 2009, 7(10):e1000215.
84. Yumoto N., Wakatsuki S., Kurisaki T., Hara Y., Osumi N., Frisén J., et al. Meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PLoS One 2008, 3(10):e3322.
85. Deribe Y.L., Wild P., Chandrashaker A., Curak J., Schmidt M.H., Kalaidzidis Y., et al. Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal 2009, 2(102):ra84.
86. Thelemann A., Petti F., Griffin G., Iwata K., Hunt T., Settinari T., et al. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol Cell Proteomics 2005, 4(4):356-376.
87. Komurov K., Padron D., Cheng T., Roth M., Rosenblatt K.P., White M.A. Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling. J Biol Chem 2010, 285(27):21134-21142.
88. Larsen A.B., Pedersen M.W., Stockhausen M.T., Grandal M.V., van Deurs B., Poulsen H.S. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol Cancer Res 2007, 5(3):283-293.
89. Larsen A.B., Stockhausen M.T., Poulsen H.S. Cell adhesion and EGFR activation regulate EphA2 expression in cancer. Cell Signal 2010, 22(4):636-644.
90. Brantley-Sieders D.M., Zhuang G., Hicks D., Fang W.B., Hwang Y., Cates J.M., et al. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 2008, 118(1):64-78.
91. Fukai J., Yokote H., Yamanaka R., Arao T., Nishio K., Itakura T. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Mol Cancer Ther 2008, 7(9):2768-2778.
92. Park E.K., Warner N., Bong Y.S., Stapleton D., Maeda R., Pawson T., et al. Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos. Mol Biol Cell 2004, 15(4):1647-1655.
93. Yokote H., Fujita K., Jing X., Sawada T., Liang S., Yao L., et al. Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains. Proc Natl Acad Sci USA 2005, 102(52):18866-18871.
94. Poliakov A., Cotrina M.L., Pasini A., Wilkinson D.G. Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway. J Cell Biol 2008, 183(5):933-947.
95. Kim I., Ryu Y.S., Kwak H.J., Ahn S.Y., Oh J.-L., Yancopoulos G.D., et al. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin-1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. FASEB J 2002, 1-805.
96. Ojima T., Takagi H., Suzuma K., Oh H., Suzuma I., Ohashi H., et al. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown. Am J Pathol 2006, 168(1):331-339.
97. Halford M.M., Armes J., Buchert M., Meskenaite V., Grail D., Hibbs M.L., et al. Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk. Nat Genet 2000, 25(4):414-418.
98. Halford M.M., Stacker S.A. Revelations of the RYK receptor 2001, 23(1):34-45.
99. Kamitori K., Tanaka M., Okuno-Hirasawa T., Kohsaka S. Receptor related to tyrosine kinase RYK regulates cell migration during cortical development. Biochem Biophys Res Commun 2005, 330(2):446-453.
100. Trivier E., Ganesan T.S. RYK, a catalytically inactive receptor tyrosine kinase: associates with EphB2 and EphB3 but does not interact with AF-6. J Biol Chem 2002, 277(25):23037-23043.
101. Salvucci O., de la Luz S.M., Martina J.A., McCormick P.J., Tosato G. EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood 2006, 108(9):2914-2922.
102. Sharfe N., Freywald A., Toro A., Dadi H., Roifman C. Ephrin stimulation modulates T cell chemotaxis. Eur J Immunol 2002, 32(12):3745-3755.
103. Henderson J.T., Georgiou J., Jia Z., Robertson J., Elowe S., Roder J.C., et al. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 2001, 32(6):1041-1056.
104. Dalva M.B., Takasu M.A., Lin M.Z., Shamah S.M., Hu L., Gale N.W., et al. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 2000, 103(6):945-956.
105. Takasu M.A., Dalva M.B., Zigmond R.E., Greenberg M.E. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 2002, 295(5554):491-495.
106. Prevost N., Woulfe D., Tanaka T., Brass L.F. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci USA 2002, 99(14):9219-9224.
107. Parrinello S., Napoli I., Ribeiro S., Digby P.W., Fedorova M., Parkinson D.B., et al. EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell 2010, 143(1):145-155.
108. Hess A.R., Seftor E.A., Gruman L.M., Kinch M.S., Seftor R.E., Hendrix M.J. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 2006, 5(2):228-233.
109. Orsulic S., Kemler R. Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci 2000, 113(Pt 10):1793-1802.
110. Zantek N.D., Azimi M., Fedor-Chaiken M., Wang B., Brackenbury R., Kinch M.S. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 1999, 10(9):629-638.
111. Cortina C., Palomo-Ponce S., Iglesias M., Fernandez-Masip J.L., Vivancos A., Whissell G., et al. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 2007, 39(11):1376-1383.
112. Solanas G., Cortina C., Sevillano M., Batlle E. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol 2011, 13(9):1100-1107.
113. Marston D.J., Dickinson S., Nobes C.D. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol 2003, 5(10):879-888.
114. Zimmer M., Palmer A., Kohler J., Klein R. EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nat Cell Biol 2003, 5(10):869-878.
115. Scita G., Di Fiore P.P. The endocytic matrix. Nature 2010, 463(7280):464-473.
116. Wimmer-Kleikamp S.H., Nievergall E., Gegenbauer K., Adikari S., Mansour M., Yeadon T., et al. Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood 2008, 112(3):721-732.
117. Shintani T., Ihara M., Sakuta H., Takahashi H., Watakabe I., Noda M. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nat Neurosci 2006, 9(6):761-769.
118. Nievergall E., Janes P.W., Stegmayer C., Vail M.E., Haj F.G., Teng S.W., et al. PTP1B regulates Eph receptor function and trafficking. J Cell Biol 2010, 191(6):1189-1203.
119. Batlle E., Bacani J., Begthel H., Jonkheer S., Gregorieff A., van de Born M., et al. EphB receptor activity suppresses colorectal cancer progression. Nature 2005, 435(7045):1126-1130.
120. Noren N.K., Pasquale E.B. Paradoxes of the EphB4 receptor in cancer. Cancer Res 2007, 67(9):3994-3997.
121. Merlos-Suarez A., Battle E. Eph-ephrin signalling in adult tissues and cancer. Curr Opin Cell Biol 2008, 20:194-200.
122. Balakrishnan A., Bleeker F.E., Lamba S., Rodolfo M., Daniotti M., Scarpa A., et al. Novel somatic and germline mutations in cancer candidate genes in glioblastoma: melanoma, and pancreatic carcinoma. Cancer Res 2007, 67(8):3545-3550.
123. Corbo V., Ritelli R., Barbi S., Funel N., Campani D., Bardelli A., et al. Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas. PLoS One 2010, 5(9):e12653.
124. Kan Z., Jaiswal B.S., Stinson J., Janakiraman V., Bhatt D., Stern H.M., et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466(7308):869-873.
125. Zogopoulos G., Jorgensen C., Bacani J., Montpetit A., Lepage P., Ferretti V., et al. Germline EPHB2 receptor variants in familial colorectal cancer. PLoS One 2008, 3(8):e2885.
126. Huusko P., Ponciano-Jackson D., Wolf M., Kiefer J.A., Azorsa D.O., Tuzmen S., et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat Genet 2004, 36(9):979-983.
127. Ruhe J.E., Streit S., Hart S., Wong C.H., Specht K., Knyazev P., et al. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Res 2007, 67(23):11368-11376.
128. Bae H.J., Song J.H., Noh J.H., Kim J.K., Jung K.H., Eun J.W., et al. Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma. Neoplasma 2009, 56(4):331-334.